New immunotherapy combo takes on standard chemo for hodgkin lymphoma
NCT ID NCT07234487
First seen Nov 18, 2025 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study tests whether a new combination of the immunotherapy drug nivolumab plus chemotherapy (AVD) works better and is safer than the standard BEACOPP-like chemotherapy for people with advanced Hodgkin lymphoma. About 178 adults aged 18-60 with newly diagnosed stage IIB, III, or IV disease will be randomly assigned to one of the two treatment plans. The main goal is to compare side effects and see which approach leads to better cancer control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
A.N.Bakulev Center for cardiovascular surgery of the Russian Ministry of Health
RECRUITINGMoscow, Russia
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
National Medical and Surgical Center named after N.I. Pirogov
RECRUITINGMoscow, Russia
Contact Email: •••••@•••••
-
St. Petersburg State Pavlov Medical University
RECRUITINGSaint Petersburg, Russia
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.